US Stock MarketDetailed Quotes

Actuate Therapeutics (ACTU)

Watchlist
  • 5.460
  • +0.010+0.18%
Trading Jan 23 10:17 ET
126.91MMarket Cap-5.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Actuate Therapeutics (ACTU) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1.47%5.47M
9.81%5.97M
-18.11%6.37M
0.75%25.16M
-13.87%6.56M
-16.72%5.39M
-2.67%5.44M
46.71%7.77M
23.59%24.97M
7.62M
Selling and administrative expenses
101.40%3.29M
201.52%3.2M
244.56%3.15M
98.57%6.48M
196.40%2.87M
129.05%1.64M
31.65%1.06M
17.81%912.82K
-14.51%3.27M
--969.35K
-General and administrative expense
101.40%3.29M
201.52%3.2M
244.56%3.15M
98.57%6.48M
196.40%2.87M
129.05%1.64M
31.65%1.06M
17.81%912.82K
-14.51%3.27M
--969.35K
Research and development costs
-42.03%2.18M
-36.77%2.76M
-53.06%3.22M
-13.97%18.68M
-44.54%3.69M
-34.79%3.76M
-8.47%4.37M
51.65%6.86M
32.47%21.71M
--6.65M
Operating profit
-1.47%-5.47M
-9.81%-5.97M
18.11%-6.37M
-0.75%-25.16M
13.87%-6.56M
16.72%-5.39M
2.67%-5.44M
-46.71%-7.77M
-23.59%-24.97M
-7.62M
Net non-operating interest income expense
-15.99%64.91K
445.59%19.47K
400.10%48.56K
-34.12%203.58K
106.94%113.04K
-36.09%77.26K
-96.77%3.57K
-58.14%9.71K
2,754.26%309.03K
54.63K
Non-operating interest income
-13.35%69.97K
183.79%24.53K
262.66%53.62K
-36.97%222.29K
97.89%118.12K
-35.89%80.75K
-92.51%8.65K
-71.37%14.79K
1,204.89%352.67K
--59.69K
Non-operating interest expense
45.11%5.06K
-0.28%5.06K
-0.26%5.06K
-57.11%18.72K
0.26%5.08K
-31.07%3.49K
0.28%5.08K
-82.16%5.08K
169.39%43.64K
--5.06K
Other net income (expense)
-2,816.70%-2.33M
0
-3,985.43%-655.32K
-2,171.86%-1.14M
-10,533.29%-532.52K
-318.22%-79.82K
-51.6K
Gain on sale of security
----
----
----
431.16%264.34K
--0
3,085.05%537.19K
-378.82%-240.34K
-737.05%-32.52K
-318.22%-79.82K
---51.6K
Other non- operating income (expenses)
----
----
----
---2.59M
--0
---1.19M
---900K
---500K
----
----
Income before tax
9.44%-5.41M
9.48%-5.95M
23.86%-6.32M
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-7.61M
Income tax
Net income
9.44%-5.41M
9.48%-5.95M
23.86%-6.32M
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-7.61M
Net income continuous Operations
9.44%-5.41M
9.48%-5.95M
23.86%-6.32M
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
---7.61M
Minority interest income
Net income attributable to the parent company
9.44%-5.41M
9.48%-5.95M
23.86%-6.32M
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-7.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
9.44%-5.41M
9.48%-5.95M
23.86%-6.32M
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-7.61M
Basic earnings per share
54.55%-0.25
12.76%-0.3
26.28%-0.32
-151.79%-3.26
17.14%-0.33
-34.42%-0.55
3.58%-0.3439
-27.58%-0.4341
3.45%-1.2947
-0.3983
Diluted earnings per share
54.55%-0.25
12.76%-0.3
26.28%-0.32
-151.79%-3.26
17.14%-0.33
-34.42%-0.55
3.58%-0.3439
-27.58%-0.4341
3.45%-1.2947
-0.3983
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1.47%5.47M9.81%5.97M-18.11%6.37M0.75%25.16M-13.87%6.56M-16.72%5.39M-2.67%5.44M46.71%7.77M23.59%24.97M7.62M
Selling and administrative expenses 101.40%3.29M201.52%3.2M244.56%3.15M98.57%6.48M196.40%2.87M129.05%1.64M31.65%1.06M17.81%912.82K-14.51%3.27M--969.35K
-General and administrative expense 101.40%3.29M201.52%3.2M244.56%3.15M98.57%6.48M196.40%2.87M129.05%1.64M31.65%1.06M17.81%912.82K-14.51%3.27M--969.35K
Research and development costs -42.03%2.18M-36.77%2.76M-53.06%3.22M-13.97%18.68M-44.54%3.69M-34.79%3.76M-8.47%4.37M51.65%6.86M32.47%21.71M--6.65M
Operating profit -1.47%-5.47M-9.81%-5.97M18.11%-6.37M-0.75%-25.16M13.87%-6.56M16.72%-5.39M2.67%-5.44M-46.71%-7.77M-23.59%-24.97M-7.62M
Net non-operating interest income expense -15.99%64.91K445.59%19.47K400.10%48.56K-34.12%203.58K106.94%113.04K-36.09%77.26K-96.77%3.57K-58.14%9.71K2,754.26%309.03K54.63K
Non-operating interest income -13.35%69.97K183.79%24.53K262.66%53.62K-36.97%222.29K97.89%118.12K-35.89%80.75K-92.51%8.65K-71.37%14.79K1,204.89%352.67K--59.69K
Non-operating interest expense 45.11%5.06K-0.28%5.06K-0.26%5.06K-57.11%18.72K0.26%5.08K-31.07%3.49K0.28%5.08K-82.16%5.08K169.39%43.64K--5.06K
Other net income (expense) -2,816.70%-2.33M0-3,985.43%-655.32K-2,171.86%-1.14M-10,533.29%-532.52K-318.22%-79.82K-51.6K
Gain on sale of security ------------431.16%264.34K--03,085.05%537.19K-378.82%-240.34K-737.05%-32.52K-318.22%-79.82K---51.6K
Other non- operating income (expenses) ---------------2.59M--0---1.19M---900K---500K--------
Income before tax 9.44%-5.41M9.48%-5.95M23.86%-6.32M-10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-7.61M
Income tax
Net income 9.44%-5.41M9.48%-5.95M23.86%-6.32M-10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-7.61M
Net income continuous Operations 9.44%-5.41M9.48%-5.95M23.86%-6.32M-10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M---7.61M
Minority interest income
Net income attributable to the parent company 9.44%-5.41M9.48%-5.95M23.86%-6.32M-10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-7.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 9.44%-5.41M9.48%-5.95M23.86%-6.32M-10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-7.61M
Basic earnings per share 54.55%-0.2512.76%-0.326.28%-0.32-151.79%-3.2617.14%-0.33-34.42%-0.553.58%-0.3439-27.58%-0.43413.45%-1.2947-0.3983
Diluted earnings per share 54.55%-0.2512.76%-0.326.28%-0.32-151.79%-3.2617.14%-0.33-34.42%-0.553.58%-0.3439-27.58%-0.43413.45%-1.2947-0.3983
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.17%
Sample Name
Sample Code
 +2.92%
Sample Name
Sample Code
 +2.36%
4
Clean Energy Fuels
CLNE
+2.19%
5
NVIDIA
NVDA
+1.52%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.21%
Sample Name
Sample Code
 +8.74%
Sample Name
Sample Code
 +4.20%
4
Pony AI
PONY
+4.09%
5
KE Holdings
BEKE
+4.07%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -